- Home
- PRTA vs SRTA Comparison
PRTA vs SRTA Comparison
Compare PRTA & SRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- SRTA
- Stock Information
- Founded
- PRTA 2012
- SRTA 2014
- Country
- PRTA Ireland
- SRTA United States
- Employees
- PRTA N/A
- SRTA N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- SRTA
- Sector
- PRTA Health Care
- SRTA
- Exchange
- PRTA Nasdaq
- SRTA Nasdaq
- Market Cap
- PRTA 472.1M
- SRTA 438.4M
- IPO Year
- PRTA N/A
- SRTA N/A
- Fundamental
- Price
- PRTA $9.92
- SRTA $4.99
- Analyst Decision
- PRTA Buy
- SRTA Strong Buy
- Analyst Count
- PRTA 9
- SRTA 1
- Target Price
- PRTA $13.14
- SRTA $7.25
- AVG Volume (30 Days)
- PRTA 785.0K
- SRTA 839.4K
- Earning Date
- PRTA 11-11-2025
- SRTA 11-10-2025
- Dividend Yield
- PRTA N/A
- SRTA N/A
- EPS Growth
- PRTA N/A
- SRTA N/A
- EPS
- PRTA N/A
- SRTA N/A
- Revenue
- PRTA $10,341,000.00
- SRTA $254,341,000.00
- Revenue This Year
- PRTA N/A
- SRTA N/A
- Revenue Next Year
- PRTA $602.32
- SRTA $28.16
- P/E Ratio
- PRTA N/A
- SRTA N/A
- Revenue Growth
- PRTA N/A
- SRTA 6.70
- 52 Week Low
- PRTA $4.32
- SRTA $3.85
- 52 Week High
- PRTA $18.88
- SRTA $6.02
- Technical
- Relative Strength Index (RSI)
- PRTA 55.31
- SRTA N/A
- Support Level
- PRTA $9.98
- SRTA N/A
- Resistance Level
- PRTA $10.90
- SRTA N/A
- Average True Range (ATR)
- PRTA 0.47
- SRTA 0.00
- MACD
- PRTA -0.06
- SRTA 0.00
- Stochastic Oscillator
- PRTA 23.93
- SRTA 0.00
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
About SRTA Strata Critical Medical Inc. Class A Common Stock
Strata Critical Medical Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs.